 CAMBRIDGE, Mass., May 25, 2022 GLOBE NEWSWIRE -- Cerevel Therapeutics Nasdaq: CERE, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that chairperson and chief executive officer Tony Coles, M.D. will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 8 at 10:30 am ET. 